Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

5.01

+0.02 (0.40%)

At close: Oct 29, 2025, 4:00 PM EDT

4.990

-0.020 (-0.40%)

Pre-market: Oct 30, 2025, 8:46 AM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Adeno-Associated Viruses-based Gene Therapies	15.45M	Log In
Adeno-Associated Viruses-based Gene Therapies Growth	517.55%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.